Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis
暂无分享,去创建一个
[1] Ponnada A Narayana,et al. Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[2] G. Barker,et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[3] W. I. McDonald,et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.
[4] A. Thompson,et al. Primary progressive multiple sclerosis: a 5-year clinical and MR study. , 2003, Brain : a journal of neurology.
[5] M Filippi,et al. Enhanced magnetic resonance imaging in multiple sclerosis , 2000, Multiple sclerosis.
[6] A J Thompson,et al. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow‐up study , 2001, European journal of neurology.
[7] Rohit Bakshi,et al. The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction , 2005, NeuroImage.
[8] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[9] A. Thompson,et al. The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis-preliminary results , 2001, Multiple sclerosis.
[10] D. Louis Collins,et al. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients , 2005, NeuroImage.
[11] A. Thompson,et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.
[12] Rohit Bakshi,et al. Short-term brain atrophy changes in relapsing–remitting multiple sclerosis , 2004, Journal of the Neurological Sciences.
[13] R. Bakshi,et al. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. , 2001, Archives of neurology.
[14] David H. Miller,et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.
[15] J. Simon. Brain and Spinal Cord Atrophy in Multiple Sclerosis , 2000, CNS drugs.
[16] H. McFarland,et al. Ring-enhancement in multiple sclerosis: marker of disease severity , 2001, Multiple sclerosis.
[17] J H Simon,et al. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. , 1998, Annals of neurology.
[18] R. Bakshi,et al. Measurement of Brain and Spinal Cord Atrophy by Magnetic Resonance Imaging as a Tool to Monitor Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[19] G. B. Pike Ph. D.,et al. Magnetization transfer imaging of multiple sclerosis , 2005, The Italian Journal of Neurological Sciences.
[20] R. Kikinis,et al. The evolution of multiple sclerosis lesions on serial MR. , 1995, AJNR. American journal of neuroradiology.
[21] D. Li,et al. Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. , 1999, Annals of neurology.
[22] D. Auer,et al. Spinal Cord Imaging in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[23] Hompson,et al. A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .
[24] C. Svarer,et al. Correlations of brain MRI parameters to disability in multiple sclerosis , 2001, Acta neurologica Scandinavica.
[25] Jeanelle Sheeder,et al. Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis , 1998 .
[26] R. Bakshi,et al. Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis , 1998, European journal of neurology.
[27] J K Udupa,et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images--lack of correlation between changes in T2 lesion volume and clinical findings. , 1999, Radiology.
[28] D. Paty,et al. Magnetic resonance imaging results of the PRISMS trial: A randomized, double‐blind, placebo‐controlled study of interferon‐β1a in relapsing‐remitting multiple sclerosis , 1999 .
[29] A. Thompson,et al. One year follow up study of primary and transitional progressive multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.
[30] N. Richert. Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". , 2002, Neurology.
[31] Moses Rodriguez,et al. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.
[32] A. Thompson,et al. Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration , 1992, Neurology.
[33] G Tedeschi,et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.
[34] Mara Cercignani,et al. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. , 2005, Brain : a journal of neurology.
[35] Frederik Barkhof,et al. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS) , 1999, Multiple sclerosis.
[36] P. Dastidar,et al. Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis , 1999, Journal of the Neurological Sciences.
[37] Rohit Bakshi,et al. Role of MRI in multiple sclerosis I: inflammation and lesions. , 2004, Frontiers in bioscience : a journal and virtual library.
[38] A. Thompson,et al. T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. , 2001, Brain : a journal of neurology.
[39] Rohit Bakshi,et al. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. , 2004, Frontiers in bioscience : a journal and virtual library.
[40] L. Kappos,et al. Clinical–MRI correlations in a European trial of interferon beta-1b in secondary progressive MS , 2001, Neurology.
[41] Alan C. Evans,et al. Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods. , 1998, Brain : a journal of neurology.
[42] A J Thompson,et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.
[43] F. Barkhof,et al. The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS , 2001, Neurology.
[44] A J Thompson,et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.
[45] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[46] R. Rudick,et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS , 2001, Neurology.
[47] W. Mcdonald,et al. Patterns of blood-brain barrier breakdown in inflammatory demyelination. , 1991, Brain : a journal of neurology.
[48] G Cutter,et al. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. , 2000, Multiple sclerosis.
[49] Rohit Bakshi,et al. A semiautomated measure of whole-brain atrophy in multiple sclerosis , 2003, Journal of the Neurological Sciences.
[50] F. Barkhof,et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.
[51] H. McFarland,et al. Immunopathogenesis of the multiple sclerosis lesion , 2001, Current neurology and neuroscience reports.
[52] Nick C Fox,et al. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.
[53] Rohit Bakshi,et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.
[54] F. Barkhof,et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.
[55] A J Thompson,et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[56] Massimo Filippi,et al. Magnetic Resonance Imaging Monitoring of Multiple Sclerosis Lesion Evolution , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[57] J H Simon,et al. Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.
[58] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[59] J A Maldjian,et al. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. , 2000, AJNR. American journal of neuroradiology.
[60] Roland Martin,et al. Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.
[61] Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. , 1995, Neurology.
[62] A. Thompson,et al. Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study , 2004, Multiple sclerosis.
[63] P. M. Matthews,et al. Evidence of early cortical atrophy in MS , 2003, Neurology.
[64] Ludwig Kappos,et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.
[65] F Barkhof,et al. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity. , 1999, Archives of neurology.
[66] G Cazzato,et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[67] C. Tench,et al. Measurement of Spinal Cord Atrophy in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[68] A J Thompson,et al. Gray and white matter volume changes in early RRMS , 2005, Neurology.
[69] Neal Jeffries,et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. , 2003, Brain : a journal of neurology.
[70] Bruno Alfano,et al. Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load , 2003, NeuroImage.
[71] F. Barkhof,et al. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients , 2005, Neurology.
[72] H. Tobi,et al. Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.
[73] D. Paty,et al. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.
[74] Caterina Mainero,et al. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with ‘black holes’, disease duration and clinical disability , 2000, Journal of the Neurological Sciences.
[75] Marco Rovaris,et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. , 2003, Brain : a journal of neurology.
[76] Frederik Barkhof,et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. , 2003, Archives of neurology.
[77] D. Miller,et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.
[78] G. Comi,et al. New Frontiers of MR-based Techniques in Multiple Sclerosis , 2003, Topics in Neuroscience.
[79] F. Barkhof,et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.
[80] Rohit Bakshi,et al. Central Nervous System Atrophy and Clinical Status in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[81] H. McFarland,et al. Contrast-enhanced MRI lesions during treatment with interferonβ-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis , 2005, Multiple sclerosis.
[82] M. Horsfield,et al. A 6‐year clinical and MRI follow‐up study of patients with relapsing–remitting multiple sclerosis treated with Interferon‐beta , 2002, European journal of neurology.
[83] A J Thompson,et al. Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis , 1995, Neurology.
[84] À. Rovira,et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. , 1999, AJNR. American journal of neuroradiology.
[85] A. Thompson,et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.
[86] L G Nyúl,et al. Relapsing-remitting Multiple Sclerosis: Fractional Volumetric Analysis of Gray Matter and White Matter , 2000 .
[87] F. Barkhof,et al. Correlations between monthly enhanced MRI Lesion rate and changes in T2 Lesion volume in multiple sclerosis , 1998, Annals of neurology.
[88] F. Barkhof,et al. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker , 2001, Neurology.
[89] Hans Lassmann,et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.
[90] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[91] M. Gobbini,et al. Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. , 2001, Archives of neurology.
[92] G J Barker,et al. The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.
[93] Richard A. C. Hughes,et al. PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS , 2001, Neurology.